Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome
Recruiting
Observational Study
Obstructive Sleep Apnea
Down Syndrome (Trisomy 21)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 5 Months – 6 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Hospices Civils de Lyon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Obstructive Sleep Apnea (OSA) is characterised by repetitive collapse of the upper airway during sleep, inducing breathing disturbances that can result in oxygen desaturation and frequent arousals. In children, OSA can have long-term consequences on the development and on the cardiovascular system.
Down Syndrome (DS) is a genetic disorder associated with intellectual disability and many comorbidi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
(infants with Down Syndrome)
* Aged 6 months (±3 weeks)
* Diagnosed with Trisomy 21
* Affiliated to a social security scheme
* With informed consent of the 2 legal representatives
Exclusion Criteria:
* Diagnosed with mosaic Down syndrome
* Born preterm (gestation age at birth…
Contacts